NO163227C - Fremgangsm te for fremstilling av 1-substituert-aryihydro-4-oksonaftyridin-derivater. - Google Patents

Fremgangsm te for fremstilling av 1-substituert-aryihydro-4-oksonaftyridin-derivater.

Info

Publication number
NO163227C
NO163227C NO860226A NO860226A NO163227C NO 163227 C NO163227 C NO 163227C NO 860226 A NO860226 A NO 860226A NO 860226 A NO860226 A NO 860226A NO 163227 C NO163227 C NO 163227C
Authority
NO
Norway
Prior art keywords
oxonaftyridine
aryi
hydro
derivatives
substituted
Prior art date
Application number
NO860226A
Other languages
English (en)
Norwegian (no)
Other versions
NO163227B (no
NO860226L (no
Inventor
Yozo Todo
Tetsuo Yamafuji
Katsuyuki Nagumo
Isao Kitayama
Hideyoshi Nagaki
Mikako Miyajima
Yoshinori Konishi
Hirokazu Narita
Shuntaro Takano
Isamu Saikawa
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP60009191A external-priority patent/JPH0629247B2/ja
Priority claimed from JP60028397A external-priority patent/JPH0629246B2/ja
Priority claimed from JP60043644A external-priority patent/JPH0665670B2/ja
Priority claimed from JP60069061A external-priority patent/JPH0665671B2/ja
Priority claimed from JP60097065A external-priority patent/JPH0662619B2/ja
Priority claimed from JP60129323A external-priority patent/JPH0665672B2/ja
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of NO860226L publication Critical patent/NO860226L/no
Priority to NO892693A priority Critical patent/NO167804C/no
Priority to NO892692A priority patent/NO174888C/no
Publication of NO163227B publication Critical patent/NO163227B/no
Publication of NO163227C publication Critical patent/NO163227C/no
Priority to NO924181A priority patent/NO178574C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO860226A 1985-01-23 1986-01-22 Fremgangsm te for fremstilling av 1-substituert-aryihydro-4-oksonaftyridin-derivater. NO163227C (no)

Priority Applications (3)

Application Number Priority Date Filing Date Title
NO892693A NO167804C (no) 1985-01-23 1989-06-28 Fremgangsmaate for fremstilling av 1-substituert-fenyl-1,4-dihydro-4-oksonaftyridin-derivater.
NO892692A NO174888C (no) 1985-01-23 1989-06-28 Nye 2-(5-fluornikotinoyl)-eddiksyrederivater
NO924181A NO178574C (no) 1985-01-23 1992-10-29 Nye 5-fluornikotinsyrederivater

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP60009191A JPH0629247B2 (ja) 1985-01-23 1985-01-23 ５−フルオロニコチン酸誘導体およびその塩
JP60028397A JPH0629246B2 (ja) 1985-02-18 1985-02-18 ２−（５−フルオロニコチノイル）酢酸誘導体およびその塩
JP60043644A JPH0665670B2 (ja) 1985-03-07 1985-03-07 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
JP60069061A JPH0665671B2 (ja) 1985-04-03 1985-04-03 １−置換アリ−ル−１，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩の新規製造法
JP60097065A JPH0662619B2 (ja) 1985-05-08 1985-05-08 １，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩の新規製造法
JP60129323A JPH0665672B2 (ja) 1985-06-14 1985-06-14 １，４−ジヒドロ−４−オキソナフチリジン誘導体またはその塩の新規製造法

Publications (3)

Publication Number Publication Date
NO860226L NO860226L (no) 1986-07-24
NO163227B NO163227B (no) 1990-01-15
NO163227C true NO163227C (no) 1990-04-25

Family

ID=27548185

Family Applications (1)

Application Number Title Priority Date Filing Date
NO860226A NO163227C (no) 1985-01-23 1986-01-22 Fremgangsm te for fremstilling av 1-substituert-aryihydro-4-oksonaftyridin-derivater.

Country Status (20)

Country Link
US (1) US4704459A (de)
KR (1) KR880001078B1 (de)
AT (1) AT392789B (de)
BE (1) BE904086A (de)
CA (2) CA1340706C (de)
CH (2) CH671957A5 (de)
DE (2) DE3637679C1 (de)
DK (3) DK169570B1 (de)
FI (2) FI83313C (de)
FR (1) FR2576305B1 (de)
GB (2) GB2170804B (de)
IL (1) IL77688A (de)
IT (1) IT1190193B (de)
LU (1) LU86264A1 (de)
NL (1) NL192986C (de)
NO (1) NO163227C (de)
NZ (1) NZ214901A (de)
PH (2) PH23202A (de)
PT (1) PT81889B (de)
SE (3) SE462164B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
US4916229A (en) * 1987-07-28 1990-04-10 Warner-Lambert Company Pyridine carboxylic acid derivates
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
DE3729852A1 (de) * 1987-09-05 1989-03-23 Basf Ag Verfahren zur herstellung von 1-alkylimidazol-5-carbonsaeuren sowie deren estern, amiden und nitrilen
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
US5585491A (en) * 1988-01-25 1996-12-17 Otsuka Pharmaceutical Co., Ltd. Antibacterial agents
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
CA2100242A1 (en) * 1991-01-14 1992-07-15 Soon K. Moon Quinolone compounds and processes for preparation thereof
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
CA2168764C (en) * 1993-08-13 2000-01-18 Sung June Yoon Novel quinolone carboxylic acid derivatives
WO1996002275A1 (fr) * 1994-07-20 1996-02-01 Toyama Chemical Co., Ltd. Onguent buccal a liberation prolongee
WO1999000393A1 (en) 1997-06-26 1999-01-07 Dong Wha Pharmaceutical Industrial Co., Ltd. Quinolone carboxylic acid derivatives
US6326391B1 (en) 1998-12-04 2001-12-04 Influx, Inc. Inhibitors of multidrug transporters
MY123528A (en) * 1999-09-16 2006-05-31 Mitsubihsi Tanabe Pharma Corp Aromatic nitrogen-containing 6-membered cyclic compounds.
US7273868B2 (en) * 2000-04-28 2007-09-25 Tanabe Seiyaku Co., Ltd. Pyrazine derivatives
US20080027037A1 (en) * 2000-04-28 2008-01-31 Tanabe Seiyaku Co., Ltd. Cyclic compounds
KR100711042B1 (ko) * 2000-04-28 2007-04-24 다나베 세이야꾸 가부시키가이샤 환상 화합물
EP1364950A4 (de) * 2001-02-26 2005-03-09 Tanabe Seiyaku Co Pyridopyrimidin- und naphthyridinderivate
US6957105B2 (en) * 2002-03-26 2005-10-18 Cardiac Pacemakers, Inc. Method and apparatus for detecting oscillations in cardiac rhythm with electrogram signals
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
US7732616B2 (en) * 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
US7517994B2 (en) * 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
WO2005051302A2 (en) * 2003-11-19 2005-06-09 Array Biopharma Inc. Bicyclic inhibitors of mek and methods of use thereof
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
CA2608201C (en) * 2005-05-18 2013-12-31 Array Biopharma Inc. Heterocyclic inhibitors of mek and methods of use thereof
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
WO2007123939A2 (en) * 2006-04-19 2007-11-01 Laboratoires Serono S.A. Novel arylamino n-heteraryls as mek inhibitors
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
EP2252588A2 (de) * 2008-02-11 2010-11-24 AstraZeneca AB Verfahren zur herstellung von pyridonderivaten
AU2011315555B2 (en) 2010-10-12 2016-03-10 Elanco Animal Health Gmbh Non-starch based soft chewables
US10543170B2 (en) 2012-12-19 2020-01-28 Bayer Animal Health Gmbh Tablets with improved acceptance and good storage stability
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor
CN114727622A (zh) * 2019-09-06 2022-07-08 礼蓝美国公司 适口颗粒状兽用药组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) * 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
GB1147336A (en) * 1965-06-14 1969-04-02 Lilly Industries Ltd Quinoline-3-carboxylic acid derivatives
US3753993A (en) * 1971-05-17 1973-08-21 Sterling Drug Inc 1,4-dihydro-4-oxo-7-pyridyl-3-quinoline-carboxylic acid derivatives
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
GB1451912A (en) * 1972-08-14 1976-10-06 Dainippon Pharmaceutical Co 2-1-piperazino-5-oxopyrido-2,3-d-pyridine-6-carboxylic acids their preparation and pharmaceutical compositions thereof
US4017622A (en) * 1972-12-18 1977-04-12 Dainippon Pharmaceutical Co., Ltd. Piperazine derivatives
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
US4350817A (en) * 1980-02-28 1982-09-21 American Home Products Corporation 4-Cl, Br or I-3-Carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
DE3028520A1 (de) * 1980-07-28 1982-02-25 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur herstellung von chinolinen, naphtyridinen und anderen stickstoff-bi-heterocyclen
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS60228479A (ja) * 1984-04-26 1985-11-13 Toyama Chem Co Ltd １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Also Published As

Publication number Publication date
FI87647B (fi) 1992-10-30
GB8601045D0 (en) 1986-02-19
NL192986C (nl) 1998-07-03
PH22956A (en) 1989-02-03
IT8647562A0 (it) 1986-01-22
DE3601517C2 (de) 1989-11-16
DE3637679C1 (de) 1992-08-27
CH671957A5 (de) 1989-10-13
GB2170804B (en) 1989-09-20
FI860250A0 (fi) 1986-01-20
DE3601517A1 (de) 1986-08-21
BE904086A (fr) 1986-07-22
FI83313B (fi) 1991-03-15
IL77688A (en) 1991-01-31
FI893075A (fi) 1989-06-22
DK32286A (da) 1986-07-24
US4704459A (en) 1987-11-03
NL192986B (nl) 1998-03-02
DK170857B1 (da) 1996-02-12
DK169570B1 (da) 1994-12-05
GB2204040B (en) 1989-09-20
GB2204040A (en) 1988-11-02
DK285290A (da) 1990-11-30
SE8902265L (sv) 1989-06-21
CA1340783C (en) 1999-10-12
NO163227B (no) 1990-01-15
PT81889A (en) 1986-02-01
NZ214901A (en) 1989-01-27
AT392789B (de) 1991-06-10
LU86264A1 (fr) 1986-08-04
DK285290D0 (da) 1990-11-30
PT81889B (pt) 1988-05-27
GB2170804A (en) 1986-08-13
FR2576305B1 (fr) 1991-04-19
SE469983B (sv) 1993-10-18
FR2576305A1 (fr) 1986-07-25
FI893075A0 (fi) 1989-06-22
SE8902265D0 (sv) 1989-06-21
SE8600274D0 (sv) 1986-01-22
FI87647C (fi) 1993-02-10
DK170532B1 (da) 1995-10-16
SE469984B (sv) 1993-10-18
SE8902264L (sv) 1989-06-21
SE462164B (sv) 1990-05-14
GB8811645D0 (en) 1988-06-22
SE8600274L (sv) 1986-09-10
IT1190193B (it) 1988-02-16
DK285190D0 (da) 1990-11-30
PH23202A (en) 1989-06-06
FI83313C (fi) 1991-06-25
CH667456A5 (de) 1988-10-14
DK285190A (da) 1990-11-30
CA1340706C (en) 1999-08-17
ATA7286A (de) 1990-11-15
NO860226L (no) 1986-07-24
NL8600138A (nl) 1986-08-18
FI860250A (fi) 1986-07-24
SE8902264D0 (sv) 1989-06-21
KR880001078B1 (ko) 1988-06-22
KR860005817A (ko) 1986-08-13
DK32286D0 (da) 1986-01-22

Similar Documents

Publication Publication Date Title
NO163227C (no) Fremgangsm te for fremstilling av 1-substituert-aryihydro-4-oksonaftyridin-derivater.
NO874764D0 (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
NO870579L (no) Fremgangsmaate for fremstilling av indolizin-derivater.
NO861956L (no) Fremgangsmaate for fremstilling av askorbinsyrederivater.
NO862650L (no) Fremgangsmaate for fremstilling av isoksazol- og furanderivater.
NO865013D0 (no) Fremgangsmaate for fremstilling av antibaktercelle kinolon-derivater.
NO862861L (no) Fremgangsmaate for fremstilling av distamycinderivater.
NO171592C (no) Fremgangsmaate for fremstilling av aktive cinnolin-derivater
NO864782D0 (no) Fremgangsmaate ved fremstilling av kinolon-derivater.
NO163453C (no) Fremgangsmaate for fremstilling av sphingosinderivater.
NO861474L (no) Fremgangsmaate ved fremstilling av fenetanolaminderivater.
NO851920L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO860429L (no) Fremgangsmaate for fremstilling av imidazolyl-indol-derivater.
NO880294L (no) Fremgangsmaate for fremstilling av tetrahydrofuranderivater
NO853771L (no) Fremgangsm¨te for fremstilling av pyrido-imidazo-rifamycin -derivater.
NO169441C (no) Fremgangsmaate til fremstilling av 7-oksomitosanderivater
NO874199D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinonderivater.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
NO863414L (no) Fremgangsmaate til fremstilling av hydropyridinderivater.
NO852796L (no) Fremgangsmaate for fremstilling av nitroapovincamin-syrederivater.
NO864087L (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
NO862493L (no) Fremgangsmaate for fremstilling av 2-halonicergolinderivater.
NO851319L (no) Fremgangsmaate for fremstilling av eburnanderivater.
NO872683D0 (no) Fremgangsmaate for fremstilling av difenylazometinderivater
NO874698D0 (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivater.